ATE477796T1 - (+)-cycloolivil als antioxidationsmittel gewonnen aus stereospermum personatum - Google Patents

(+)-cycloolivil als antioxidationsmittel gewonnen aus stereospermum personatum

Info

Publication number
ATE477796T1
ATE477796T1 AT01965550T AT01965550T ATE477796T1 AT E477796 T1 ATE477796 T1 AT E477796T1 AT 01965550 T AT01965550 T AT 01965550T AT 01965550 T AT01965550 T AT 01965550T AT E477796 T1 ATE477796 T1 AT E477796T1
Authority
AT
Austria
Prior art keywords
cycloolivil
stereospermum personatum
antioxidant
antioxidant obtained
personatum
Prior art date
Application number
AT01965550T
Other languages
English (en)
Inventor
Janaswamy Madhusudana Rao
Ashok Tiwari
Upparapalli Kumar
Jhillu Yadav
Kondapuram Raghavan
Original Assignee
Council Scient Ind Res
Arya Vaidya Sala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res, Arya Vaidya Sala filed Critical Council Scient Ind Res
Application granted granted Critical
Publication of ATE477796T1 publication Critical patent/ATE477796T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
AT01965550T 2001-07-27 2001-08-20 (+)-cycloolivil als antioxidationsmittel gewonnen aus stereospermum personatum ATE477796T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/917,604 US6562381B2 (en) 2001-07-27 2001-07-27 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
PCT/IN2001/000147 WO2003011268A1 (en) 2001-07-27 2001-08-20 (+)-cycloolivil as antioxidant obtained from stereospermum personatum

Publications (1)

Publication Number Publication Date
ATE477796T1 true ATE477796T1 (de) 2010-09-15

Family

ID=25439040

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01965550T ATE477796T1 (de) 2001-07-27 2001-08-20 (+)-cycloolivil als antioxidationsmittel gewonnen aus stereospermum personatum

Country Status (9)

Country Link
US (1) US6562381B2 (de)
EP (1) EP1411910B1 (de)
JP (1) JP2005500343A (de)
KR (1) KR100750372B1 (de)
CN (1) CN100438860C (de)
AT (1) ATE477796T1 (de)
CA (1) CA2455566C (de)
DE (1) DE60142857D1 (de)
WO (1) WO2003011268A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105859804A (zh) * 2016-04-27 2016-08-17 江西普正制药有限公司 一种杜仲提取物及其制备方法和应用
CN111116331A (zh) * 2019-12-11 2020-05-08 中南大学湘雅医院 环橄榄树脂素及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4875026A (en) * 1987-08-17 1989-10-17 W. L. Gore & Associates, Inc. Dielectric waveguide having higher order mode suppression
JP3138407B2 (ja) * 1995-06-22 2001-02-26 株式会社クボタ 青果物の栽培管理装置
CA2186654A1 (en) * 1995-10-13 1997-04-14 Masayuki Nakamura Phosphoric diester

Also Published As

Publication number Publication date
CN1536991A (zh) 2004-10-13
CA2455566C (en) 2010-05-04
KR20040019360A (ko) 2004-03-05
DE60142857D1 (de) 2010-09-30
EP1411910A1 (de) 2004-04-28
JP2005500343A (ja) 2005-01-06
US6562381B2 (en) 2003-05-13
EP1411910B1 (de) 2010-08-18
WO2003011268A1 (en) 2003-02-13
CA2455566A1 (en) 2003-02-13
CN100438860C (zh) 2008-12-03
US20030026862A1 (en) 2003-02-06
KR100750372B1 (ko) 2007-08-17

Similar Documents

Publication Publication Date Title
ATE433447T1 (de) Pyrimiidinverbindungen
NO20025719D0 (no) Nye triazolpyrimidinforbindelser
BRPI0412659A (pt) isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
EA200400606A1 (ru) ИНГИБИТОРЫ ФАКТОРА Ха И ДРУГИХ СЕРИНОВЫХ ПРОТЕАЗ, ВОВЛЕЧЁННЫХ В КОАГУЛЯЦИОННЫЙ КАСКАД
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
AU2003228770A8 (en) Substituted pyrazolopyrimidines
DE60112330D1 (en) Pyrazolopyridinderivate
MXPA05012837A (es) Inhibidores de caspasa y usos de los mismos.
SE0103710D0 (sv) Compounds
MY139454A (en) 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
GB0327323D0 (en) Novel pharmaceuticals
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA05013012A (es) Formulaciones blanqueadoras fluorescentes estables al almacenamiento.
BR0311970A (pt) Novos compostos, seu uso e preparação
BR0308601A (pt) inibidores de carboxipeptidase b de plasma
ATE477796T1 (de) (+)-cycloolivil als antioxidationsmittel gewonnen aus stereospermum personatum
MX2022004265A (es) Compuesto de aldehido y metodo para producir el mismo y composicion de fragancia.
MXPA05012004A (es) Nuevos bioisosteros de actinonina.
MEP16708A (en) Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
DE50311388D1 (de) Nicht-peptidische brs-3-agonisten
EA200300400A1 (ru) 17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
DE60108272D1 (de) Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol
NO20033400L (no) Fremgangsmåte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties